Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Jan J. De Waele, Sofie Carrette et al.|Critical Care|2013Cited by 212
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trialJan J. De Waele, Alain Verstraete, Sofie Carrette et al.|Intensive Care Medicine|2013Cited by 190
Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured reviewMieke Carlier, Jason A. Roberts, Veronique Stove et al.|International Journal of Antimicrobial Agents|2015Cited by 112
Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS methodMieke Carlier, Alain Verstraete, Veronique Stove et al.|International Journal of Antimicrobial Agents|2012Cited by 92
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI StudyJason A. Roberts, Jeffrey Lipman, Veronique Stove et al.|International Journal of Antimicrobial Agents|2014Cited by 77